 CARLSBAD, Calif.--BUSINESS WIRE--- LCTX CFO--Lineage Cell Therapeutics, Inc. NYSE American and TASE: LCTX, a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, announced today that Kevin Cook will join as the Companys Chief Financial Officer, effective June 21, 2021. Mr. Cook will bring more than 20 years of significant strategic, financial, and operational experience to Lineage, with an emphasis in private equity, corporate finance, and investment banki 